Q9Z1S0
Gene name |
Bub1b (Mad3l) |
Protein name |
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta |
Names |
MAD3/BUB1-related protein kinase, BubR1, Mitotic checkpoint kinase MAD3L |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:12236 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9Z1S0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9Z1S0-F1 | Predicted | AlphaFoldDB |
69 variants for Q9Z1S0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388568016 | 52 | Q>K | No | EVA | |
| rs3388574994 | 62 | F>L | No | EVA | |
| rs3388578608 | 62 | F>Y | No | EVA | |
| rs3388578560 | 88 | K>E | No | EVA | |
| rs3388573459 | 109 | Y>C | No | EVA | |
| rs3388578604 | 117 | S>T | No | EVA | |
| rs3388577513 | 118 | L>H | No | EVA | |
| rs3388580903 | 147 | Q>* | No | EVA | |
| rs3388573757 | 161 | N>S | No | EVA | |
| rs3388578926 | 163 | K>R | No | EVA | |
| rs260420886 | 168 | I>L | No | EVA | |
| rs260420886 | 168 | I>V | No | EVA | |
| rs3388573474 | 171 | E>D | No | EVA | |
| rs3388573448 | 185 | S>T | No | EVA | |
| rs257555947 | 206 | E>D | No | EVA | |
| rs3144766 | 240 | G>S | No | EVA | |
| rs3388577363 | 255 | V>F | No | EVA | |
| rs27423868 | 275 | A>T | No | EVA | |
| rs3149979 | 278 | T>P | No | EVA | |
| rs3149980 | 312 | A>V | No | EVA | |
| rs219981693 | 324 | T>M | No | EVA | |
| rs237393703 | 326 | I>V | No | EVA | |
| rs3388579498 | 410 | A>V | No | EVA | |
| rs217895491 | 430 | K>R | No | EVA | |
| rs232834473 | 445 | R>K | No | EVA | |
| rs244866841 | 451 | A>T | No | EVA | |
| rs3388577333 | 452 | V>L | No | EVA | |
| rs3388580921 | 461 | Q>H | No | EVA | |
| rs3392120757 | 481 | E>A | No | EVA | |
| rs3392012923 | 482 | M>L | No | EVA | |
| rs261835884 | 491 | I>V | No | EVA | |
| rs3388583046 | 493 | P>L | No | EVA | |
| rs3388579686 | 524 | F>V | No | EVA | |
| rs3388578615 | 526 | E>V | No | EVA | |
| rs259659399 | 538 | T>A | No | EVA | |
| rs3388577305 | 540 | G>D | No | EVA | |
| rs3388579707 | 544 | L>F | No | EVA | |
| rs224444372 | 545 | N>S | No | EVA | |
| rs3392092024 | 567 | S>T | No | EVA | |
| rs3392096726 | 579 | P>H | No | EVA | |
| rs3388575400 | 639 | G>R | No | EVA | |
| rs253083331 | 644 | A>G | No | EVA | |
| rs27423851 | 664 | E>D | No | EVA | |
| rs3388578838 | 683 | S>N | No | EVA | |
| rs3388581656 | 688 | K>Q | No | EVA | |
| rs223396652 | 699 | T>S | No | EVA | |
| rs3388578846 | 699 | T>S | No | EVA | |
| rs27423850 | 705 | D>N | No | EVA | |
| rs3388582495 | 707 | I>N | No | EVA | |
| rs3392115409 | 713 | S>* | No | EVA | |
| rs3388568062 | 714 | Q>H | No | EVA | |
| rs3388582508 | 721 | K>N | No | EVA | |
| rs221982013 | 726 | L>F | No | EVA | |
| rs252392177 | 726 | L>I | No | EVA | |
| rs240575644 | 738 | P>A | No | EVA | |
| rs261302866 | 741 | V>A | No | EVA | |
| rs3388571694 | 771 | W>* | No | EVA | |
| rs3388580076 | 782 | M>I | No | EVA | |
| rs3388582460 | 842 | F>Y | No | EVA | |
| rs3388575430 | 844 | T>I | No | EVA | |
| rs3388568049 | 888 | D>G | No | EVA | |
| rs253084732 | 940 | H>Q | No | EVA | |
| rs3388581730 | 948 | D>N | No | EVA | |
| rs13474781 | 959 | L>F | No | EVA | |
| rs3388573699 | 1006 | A>G | No | EVA | |
| rs237435355 | 1011 | G>V | No | EVA | |
| rs255648683 | 1018 | H>Q | No | EVA | |
| rs3388578845 | 1040 | Q>H | No | EVA | |
| rs231678555 | 1045 | P>S | No | EVA |
1 associated diseases with Q9Z1S0
Without disease ID
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
7 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| kinetochore | A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules. |
| mitotic checkpoint complex | A multiprotein complex that functions as a mitotic checkpoint inhibitor of the anaphase-promoting complex/cyclosome (APC/C). In budding yeast this complex consists of Mad2p, Mad3p, Bub3p and Cdc20p, and in mammalian cells it consists of MAD2, BUBR1, BUB3, and CDC20. |
| outer kinetochore | The region of a kinetochore most external to centromeric DNA; this outer region mediates kinetochore-microtubule interactions. |
| perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
| spindle | The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
| protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
| protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| cell division | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
| meiotic sister chromatid cohesion, centromeric | The cell cycle process in which centromeres of sister chromatids are joined during meiosis. |
| metaphase/anaphase transition of mitotic cell cycle | The cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin. |
| mitotic spindle assembly checkpoint signaling | A signal transduction process that contributes to a mitotic cell cycle spindle assembly checkpoint, that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle. |
| negative regulation of ubiquitin-protein transferase activity | Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity. |
| protein localization to chromosome, centromeric region | Any process in which a protein is transported to, or maintained at, the centromeric region of a chromosome. |
| protein phosphorylation | The process of introducing a phosphate group on to a protein. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAEASEAMCL | EGAEWELSKE | NIQPLRHGRV | MSTLQGALAK | QESAGHTALQ | QQKRAFESEI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| RFYSGDDPLD | VWDRYINWTE | QNYPQGGKES | NMSALVERAI | EALQGETRYY | NDPRFLSLWI |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KLGHLCNEPL | DMYSYLQSQG | IGVSLAQFYI | SWAEEYEARE | NFKKADIIFQ | EGIERKAEPL |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DRLQSQHRQF | QSRVSRQAFL | ALGNEEEEAL | EPSEPQRSSL | AELKSRGKKM | ARAPISRVGG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ALKAPGQSRG | FLNAVPQPVH | GNRRITVFDE | NADTASRTEL | SKPVAQPWMA | PPVPRAKENE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LQPGPWSTDR | PAGRRPHDNP | ASVTSIPSVL | PSFTPYVEES | AQQTVMTPCK | IEPSINHVLS |
| 370 | 380 | 390 | 400 | 410 | 420 |
| TRKPGREEGD | PLQRVQSHQQ | GCEEKKEKMM | YCKEKIYAGV | GEFSFEEIRA | EVFRKKLKER |
| 430 | 440 | 450 | 460 | 470 | 480 |
| REAELLTSAK | KREEMQKQIE | EMERRLKAMQ | AVQQEGAGGQ | QEEKMPTEDP | ARLQIASGPQ |
| 490 | 500 | 510 | 520 | 530 | 540 |
| EMSGVPLSCS | ICPLSSNPRE | ISPAENILQE | QPDSKGSSMP | FSIFDESLSD | KKDKSPATGG |
| 550 | 560 | 570 | 580 | 590 | 600 |
| PQVLNAQRRP | LSVLKTTEVG | TTNEDVSPDI | CDELTELEPL | SEDAIITGFR | NVTLCPNPED |
| 610 | 620 | 630 | 640 | 650 | 660 |
| TCDFARAARL | ASTPFHEILS | SKGIAADPEG | LLQEEDLDGK | AAEAHHTVHH | QALIIKKLSP |
| 670 | 680 | 690 | 700 | 710 | 720 |
| IIEESREATH | SSGFSRSSSS | APSTSSIKGF | QLLEKLELTN | DGAEDAIQSP | WCSQYRLQLL |
| 730 | 740 | 750 | 760 | 770 | 780 |
| KSLLELSAFA | EFSVEDRPMP | VLEIGKEIEL | GPEDYVIKQE | HLTCDDYRLF | WVAPRSSAEL |
| 790 | 800 | 810 | 820 | 830 | 840 |
| TMIKASSQPI | PWDFYINLKL | KERLNEDYDQ | LCSCCQYQDG | HVVWYQYINC | STLQNLLQHS |
| 850 | 860 | 870 | 880 | 890 | 900 |
| EFVTHEIIVL | IIYNLLTIVE | KLHRAEIVHG | DLSPRSLILR | NRIHDPYDYV | NKDDHAVRIM |
| 910 | 920 | 930 | 940 | 950 | 960 |
| DFSYSVDLRV | QLDAFAYSGF | RTAQILEGQK | ILANCSSPYH | VDLLGIADLA | HLLLFKEHLH |
| 970 | 980 | 990 | 1000 | 1010 | 1020 |
| VFWDGLLWKL | SQSTSELKDS | ELWNKFFVRI | LNASDKSTVS | VLGELAAEMG | GAFDATFHSH |
| 1030 | 1040 | 1050 | |||
| LNRALWKLGK | TISPEALLTQ | QDKQPGGSQS | PA |